Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin

Single cell transcriptomic analysis of human mesenchymal stem cells reveals limited heterogeneity

(2019) Yin Huang et al.   Cell Death & Disease

Rbm24, a target of p53, is necessary for proper expression of p53 and heart development

(2018) Min Zhang et al.   CELL DEATH AND DIFFERENTIATION

The tango of ROS and p53 in tissue stem cells

(2018) Youguo Chen et al.   CELL DEATH AND DIFFERENTIATION

A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness

(2018) Alessandra di Gennaro et al.   CELL DEATH AND DIFFERENTIATION

Basal p53 expression is indispensable for mesenchymal stem cell integrity

(2018) Siddaraju V. Boregowda et al.   CELL DEATH AND DIFFERENTIATION

Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1

(2018) Ling Fang et al.   CELL DEATH AND DIFFERENTIATION

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

(2018) Yufang Shi et al.   Nature Reviews Nephrology

p53 accumulation following cytokinesis failure in the absence of caspase-2

(2018) Yoon Lim et al.   CELL DEATH AND DIFFERENTIATION

MDM2 controls gene expression independently of p53 in both normal and cancer cells

(2018) Giuseppe Arena et al.   CELL DEATH AND DIFFERENTIATION

Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53

(2018) Mannu K. Walia et al.   Cell Death & Disease

Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy

(2018) Giuseppe Lonetto et al.   CELL DEATH AND DIFFERENTIATION

Mutant p53 as a guardian of the cancer cell

(2018) Fiamma Mantovani et al.   CELL DEATH AND DIFFERENTIATION

SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer

(2016) I Amelio et al.   CELL DEATH AND DIFFERENTIATION

Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond

(2014) Matthew C. Walsh et al.   Frontiers in Immunology

Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis

(2013) Brian Ell et al.   CANCER CELL

Guiding the osteogenic fate of mouse and human mesenchymal stem cells through feedback system control

(2013) Yoshitomo Honda et al.   Scientific Reports

The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development

(2012) R Rubio et al.   ONCOGENE

The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior

(2011) Yan Liu et al.   CELL CYCLE

BioProfiling.de: analytical web portal for high-throughput cell biology

(2011) A. V. Antonov   NUCLEIC ACIDS RESEARCH

Involvement of stromal p53 in tumor-stroma interactions

(2009) Jair Bar et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression

(2009) Guangwen Ren et al.   STEM CELLS

Soluble RANKL Induces High Bone Turnover and Decreases Bone Volume, Density, and Strength in Mice

(2008) S. A. J. Lloyd et al.   CALCIFIED TISSUE INTERNATIONAL

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

(2008) Ann E. Kearns et al.   ENDOCRINE REVIEWS

Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol

(2008) Paulette R. Dillard et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY